When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOV - Myovant Sciences inks deal for relugolix combination outside U.S.
Myovant Sciences Ltd.
Myovant Sciences (NYSE:MYOV) has entered into an exclusive license agreement with Gedeon Richter Plc., a Central Eastern Europe based pharmaceutical company where latter will commercialize relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) for uterine fibroids and endometriosis in Europe, the Commonwealth of Independent States including Russia, Latin America, Australia, and New Zealand.
More news on: Myovant Sciences Ltd., Healthcare stocks news,